Why the study?
Does TAVI with SAPIEN 3 result in different transcatheter heart valve geometry and valve function in patients with bicuspid aortic valve disease compared to those with tricuspid aortic valve disease?
Does TAVI with SAPIEN 3 result in different transcatheter heart valve geometry and valve function in patients with bicuspid aortic valve disease compared to those with tricuspid aortic valve disease?
Despite geometrical differences in valve expansion and eccentricity, TAVI with SAPIEN 3 provides feasible and comparable valve function in patients with bicuspid aortic valves compared to tricuspid aortic valves.
Answers are grounded in this paper and cite their sources.
Supports TAVI feasibility in BAV despite geometry differences; leaves open durability and outcome questions.
BAV patients have greater THV eccentricity at all levels and lower THV expansion at mid, sinus, and outflow levels than the TAV patients. There were no differences in parameters of valve function between BAV and TAV patients. Despite the observed geometrical differences, TAVI with SAPIEN 3 in BAV patients allows for feasible valve function.
No takes yet. Share an insight, caveat, or question.
Kawamori et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: